Cargando…

Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease

Mesenchymal stem cell (MSC) transplantation, as an alternative strategy to orthotopic liver transplantation, has been evaluated for treating end-stage liver disease. Although the therapeutic mechanism of MSC transplantation remains unclear, accumulating evidence has demonstrated that MSCs can regene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Mengqin, Hu, Xue, Yao, Lichao, Jiang, Yingan, Li, Lanjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066724/ https://www.ncbi.nlm.nih.gov/pubmed/35505419 http://dx.doi.org/10.1186/s13287-022-02858-4

Ejemplares similares

Identification of effective diagnostic biomarker and immune cell infiltration characteristics in acute liver failure by integrating bioinformatics analysis and machine-learning strategies
por: Yuan, Mengqin, et al.
Publicado: (2022)

Comprehensive bioinformatics and machine learning analysis identify VCAN as a novel biomarker of hepatitis B virus-related liver fibrosis
por: Yuan, Mengqin, et al.
Publicado: (2022)

Mesenchymal stromal cells: promising treatment for liver cirrhosis
por: Yao, Lichao, et al.
Publicado: (2022)

IGF2-NR4A2 Signaling Regulates Macrophage Subtypes to Attenuate Liver Cirrhosis
por: Yao, Lichao, et al.
Publicado: (2023)

Pre‐treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases
por: Hu, Chenxia, et al.
Publicado: (2019)

The immunoregulation of mesenchymal stem cells plays a critical role in improving the prognosis of liver transplantation
por: Hu, Chenxia, et al.
Publicado: (2019)

Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis
por: Hu, Chenxia, et al.
Publicado: (2019)

The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues
por: Yang, Ya, et al.
Publicado: (2021)

Enhancing mesenchymal stem cell survival and homing capability to improve cell engraftment efficacy for liver diseases
por: Yu, Shaoxiong, et al.
Publicado: (2023)

Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases
por: Hu, Chenxia, et al.
Publicado: (2019)

A pooled analysis of mesenchymal stem cell-based therapy for liver disease
por: Zhao, Lu, et al.
Publicado: (2018)

Transplantation of mesenchymal stem cells and their derivatives effectively promotes liver regeneration to attenuate acetaminophen-induced liver injury
por: Hu, Chenxia, et al.
Publicado: (2020)

The clinical application of mesenchymal stem cells in liver disease: the current situation and potential future
por: Zhang, Sainan, et al.
Publicado: (2020)

Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury
por: Hu, Chenxia, et al.
Publicado: (2020)

Mesenchymal stem cells homing to improve bone healing
por: Lin, Weiping, et al.
Publicado: (2017)

Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19
por: Tang, Lingling, et al.
Publicado: (2020)

Therapeutic potential of transplanted placental mesenchymal stem cells in treating Chinese miniature pigs with acute liver failure
por: Cao, Hongcui, et al.
Publicado: (2012)

Preconditioning influences mesenchymal stem cell properties in vitro and in vivo
por: Hu, Chenxia, et al.
Publicado: (2018)

Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma
por: Qiao, Bo, et al.
Publicado: (2015)

In Vitro and In Vivo Hepatic Differentiation of Adult Somatic Stem Cells and Extraembryonic Stem Cells for Treating End Stage Liver Diseases
por: Hu, Chenxia, et al.
Publicado: (2015)

Therapeutic Implications of Mesenchymal Stem Cells in Liver Injury
por: Puglisi, Maria Ausiliatrice, et al.
Publicado: (2011)

Role of mesenchymal stem cells, their derived factors, and extracellular vesicles in liver failure
por: Wang, Jie, et al.
Publicado: (2017)

Porcine Adipose-Derived Mesenchymal Stem Cells Retain Their Stem Cell Characteristics and Cell Activities While Enhancing the Expression of Liver-Specific Genes after Acute Liver Failure
por: Hu, Chenxia, et al.
Publicado: (2016)

Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases
por: Wang, Yini, et al.
Publicado: (2016)

Enhancement of the therapeutic efficacy of mesenchymal stem cell-derived exosomes in osteoarthritis
por: Zhang, Zehao, et al.
Publicado: (2023)

Strategies to Potentiate Paracrine Therapeutic Efficacy of Mesenchymal Stem Cells in Inflammatory Diseases
por: Seo, Yoojin, et al.
Publicado: (2021)

Potential pre-activation strategies for improving therapeutic efficacy of mesenchymal stem cells: current status and future prospects
por: Li, Meirong, et al.
Publicado: (2022)

Mesenchymal stromal cells promote liver regeneration through regulation of immune cells
por: Hu, Chenxia, et al.
Publicado: (2020)

TNF-α Preconditioning Improves the Therapeutic Efficacy of Mesenchymal Stem Cells in an Experimental Model of Atherosclerosis
por: Sekenova, Aliya, et al.
Publicado: (2023)

Melatonin plays critical role in mesenchymal stem cell-based regenerative medicine in vitro and in vivo
por: Hu, Chenxia, et al.
Publicado: (2019)

Journey of Mesenchymal Stem Cells for Homing: Strategies to Enhance Efficacy and Safety of Stem Cell Therapy
por: Kang, Sung Keun, et al.
Publicado: (2012)

Heparin improves BMSC cell therapy: Anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy
por: Liao, Li, et al.
Publicado: (2017)

The therapeutic potential of mesenchymal stem cells for cardiovascular diseases
por: Guo, Yajun, et al.
Publicado: (2020)

Transfer of Cardiac Mitochondria Improves the Therapeutic Efficacy of Mesenchymal Stem Cells in a Preclinical Model of Ischemic Heart Disease
por: Vignais, Marie-Luce, et al.
Publicado: (2023)

Innovative preconditioning strategies for improving the therapeutic efficacy of extracellular vesicles derived from mesenchymal stem cells in gastrointestinal diseases
por: Didamoony, Manar A., et al.
Publicado: (2023)

Improved therapeutics of modified mesenchymal stem cells: an update
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2020)

Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases
por: Lou, Guohua, et al.
Publicado: (2017)

Current Therapeutic Options and Potential of Mesenchymal Stem Cell Therapy for Alcoholic Liver Disease
por: Han, Jinsol, et al.
Publicado: (2022)

Overexpression of c-Met in bone marrow mesenchymal stem cells improves their effectiveness in homing and repair of acute liver failure
por: Wang, Kun, et al.
Publicado: (2017)

Interaction between Mesenchymal Stem Cells and B-Cells
por: Fan, Linxiao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_377uidsi35e6g8qjbb3c9i7r85